Detalhe da pesquisa
1.
Ductular reaction promotes intrahepatic angiogenesis through Slit2-Roundabout 1 signaling.
Hepatology
; 75(2): 353-368, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34490644
2.
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients.
J Hepatol
; 74(5): 1064-1074, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33278456
3.
Role and therapeutic potential of vascular stem/progenitor cells in pathological neovascularisation during chronic portal hypertension.
Gut
; 66(7): 1306-1320, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26984852
4.
Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.
Gastroenterology
; 150(4): 982-97.e30, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26627607
5.
Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats.
Gut
; 64(4): 657-66, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24848263
6.
Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats.
Hepatology
; 60(2): 633-47, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24390792
7.
Cell Death in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Opportunities.
Cancers (Basel)
; 14(1)2021 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008212
8.
Targeting the cytoplasmic polyadenylation element-binding protein CPEB4 protects against diet-induced obesity and microbiome dysbiosis.
Mol Metab
; 54: 101388, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774811
9.
Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension.
J Hepatol
; 52(4): 529-39, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20206401
10.
Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats.
Hepatology
; 49(4): 1245-56, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19137587
11.
Therapeutic siRNA targeting endothelial KDR decreases portosystemic collateralization in portal hypertension.
Sci Rep
; 7(1): 14791, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29093528
12.
Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension.
J Hepatol
; 50(2): 296-305, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19070926
13.
The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats.
J Cell Mol Med
; 12(5A): 1690-9, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18194463
14.
Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.
Hepatology
; 46(4): 1208-17, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17654489
15.
Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure.
J Heart Lung Transplant
; 25(9): 1117-25, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16962475